Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The patch delivers more drugs through the skin effectively.

The DWLSM provides detailed imaging of hair shafts and follicles with high accuracy.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

EFBL offers hidden incisions, faster recovery, and fewer risks, but may raise hairline and cost more.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Lamins are vital for cell survival, organ development, and preventing premature aging.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

A new liposome treatment helps heal deep burns on mice by improving hair regrowth and reducing scarring.

BMP2 and BMPR-IA may stop hair growth while Noggin may encourage it in yak skin.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

The microneedle system effectively promotes hair growth for treating androgenic alopecia.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Finasteride may help treat childhood brain tumors by activating certain genes.

Sodium pentaborate pentahydrate can increase hair growth and improve hair quality at certain doses.

The patch effectively promotes hair growth for alopecia areata without pain.

MK-386 reduces sebum DHT levels.

Basement membrane changes are crucial for hair follicle development.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.